Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. In 2006, the first research paper by Johns Hopkins was published on the positive long-term impact of using psilocybin in a therapeutic study.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

The Cannigma

AUGUST 29, 2021

The percentage of Americans over 65 who had reported using cannabis in the past year had increased tenfold between 2006 to 2018, from 0.4% The AARP, explaining its 2019 policy change, stated that its decision was based on “the growing body of research suggesting marijuana may be helpful in treating certain medical conditions and symptoms.”.

Blood Pressure 87

Blood Pressure Marijuana Conditions Sleep 87

SpeedWeed

MAY 22, 2021

2006): Another fMRI-enabled psychedelic study investigated the idea that MDMA users may be more impulsive than people that haven’t consumed the substance. She gave 25 participants 13 micrograms of LSD (a standard amount for a microdose) or a placebo in a double-blind experiment. Valdes et al. Kaelen et al.

Research and Development 52

Research and Development Microdosing Wellness and Beauty Pets 52